Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload
Open Access
- 5 September 2019
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 116 (39), 19635-19645
- https://doi.org/10.1073/pnas.1908998116
Abstract
Substance P (SP) regulates multiple biological processes through its high-affinity neurokinin-1 receptor (NK-1R). While the SP/NK-1R signaling axis is involved in the pathogenesis of solid cancer, the role of this signaling pathway in hematological malignancy remains unknown. Here, we demonstrate that NK-1R expression is markedly elevated in the white blood cells from acute myeloid leukemia patients and a panel of human leukemia cell lines. Blocking NK-1R induces apoptosis in vitro and in vivo via increase of mitochondrial reactive oxygen species. This oxidative stress was triggered by rapid calcium flux from the endoplasmic reticulum into mitochondria and, consequently, impairment of mitochondrial function, a mechanism underlying the cytotoxicity of NK-1R antagonists. Besides anticancer activity, blocking NK-1R produces a potent antinociceptive effect in myeloid leukemia-induced bone pain by alleviating inflammation and inducing apoptosis. These findings thus raise the exciting possibility that the NK-1R antagonists, drugs currently used in the clinic for preventing chemotherapy-induced nausea and vomiting, may provide a therapeutic option for treating human myeloid leukemia.Keywords
This publication has 60 references indexed in Scilit:
- Safety of neurokinin-1 receptor antagonistsExpert Opinion on Drug Safety, 2013
- Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neuronsProceedings of the National Academy of Sciences of the United States of America, 2012
- RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicingsCell Research, 2012
- SR140333 counteracts NK-1 mediated cell proliferation in human breast cancer cell line T47DJournal of Experimental & Clinical Cancer Research, 2010
- The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell LinesCancers, 2010
- Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosisOncogene, 2008
- Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptorProceedings of the National Academy of Sciences of the United States of America, 2008
- Regulation of G protein-coupled receptor export traffickingBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiationProceedings of the National Academy of Sciences of the United States of America, 2006
- Bone Cancer Pain: From Model to Mechanism to TherapyJournal of Pain and Symptom Management, 2005